Cancer Capital Corp. (CNCL) financial statements (2020 and earlier)

Company profile

Business Address 2157 S. LINCOLN
SALT LAKE CITY, UT 84106
State of Incorp. WY
Fiscal Year End December 31
SIC 677 - Blank Checks (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

9/30/2019
TTM
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments0001113
Cash and cash equivalents0001113
Total current assets:0001113
Noncurrent Assets
TOTAL ASSETS:0001113
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:4235271913781
Accounts payable 1     
Accrued liabilities  282115107
Interest and dividends payable393428211510 
Other undisclosed accounts payable and accrued liabilities3(0)(29)(23)(18)(12)74
Debt838383787165 
Due to related parties1311191079992833
Other undisclosed current liabilities39352821151056
Total current liabilities:295272244217190164140
Noncurrent Liabilities
Total liabilities:295272244217190164140
Stockholders' equity
Stockholders' equity attributable to parent, including:(295)(272)(244)(216)(190)(163)(137)
Common stock6666666
Additional paid in capital47474747474747
Accumulated deficit(348)(325)(297)(270)(243)(216) 
Other undisclosed stockholders' equity attributable to parent      (190)
Other undisclosed stockholders' equity      0
Total stockholders' equity:(295)(272)(244)(216)(190)(163)(137)
TOTAL LIABILITIES AND EQUITY:0001113

Income statement (P&L) ($ in thousands)

9/30/2019
TTM
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Operating expenses(13)(14)(13)(14)(15)(26)(28)
Other undisclosed operating income     9 
Operating loss:(13)(14)(13)(14)(15)(17)(28)
Interest and debt expense(7)(7)(6)(6)(6)(5)5
Net loss:(20)(20)(20)(20)(21)(22)(23)
Other undisclosed net loss attributable to parent(9)(8)(7)(7)(6)(4)(12)
Net loss available to common stockholders, diluted:(29)(28)(27)(27)(27)(26)(35)

Comprehensive Income ($ in thousands)

9/30/2019
TTM
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Net loss:(20)(20)(20)(20)(21)(22)(23)
Comprehensive loss, net of tax, attributable to parent:(20)(20)(20)(20)(21)(22)(23)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: